These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 880416)

  • 21. Implications of I V additive programs to the parenteral industry.
    Latiolais CJ
    Bull Parenter Drug Assoc; 1970; 24(1):45-51. PubMed ID: 5415612
    [No Abstract]   [Full Text] [Related]  

  • 22. New process for the manufacture of sterile ophthalmic ointments.
    Smith GG; Fonner DE; Griffin JC
    Bull Parenter Drug Assoc; 1975; 29(1):18-25. PubMed ID: 1125470
    [No Abstract]   [Full Text] [Related]  

  • 23. Contamination control in the pharmaceutical industry.
    Contam Control; 1971; 10(3):10-7. PubMed ID: 4258751
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pharmacy preparation of injection and other sterile solutions].
    Chirkov AI
    Voen Med Zh; 1982 May; (5):55-6. PubMed ID: 7101801
    [No Abstract]   [Full Text] [Related]  

  • 25. Proper use of biological indicators in sterilization.
    Brewer JH; Phillips GB
    Bull Parenter Drug Assoc; 1968; 22(4):157-69. PubMed ID: 4914499
    [No Abstract]   [Full Text] [Related]  

  • 26. Nanosuspensions in drug delivery.
    Rabinow BE
    Nat Rev Drug Discov; 2004 Sep; 3(9):785-96. PubMed ID: 15340388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a biological indicator control program.
    Marinaro A
    Bull Parenter Drug Assoc; 1971; 25(2):75-7. PubMed ID: 5563320
    [No Abstract]   [Full Text] [Related]  

  • 28. Panel discussion: facilities for preparing sterile products.
    Gottesman E; Holdowski S; Bassett R
    Bull Parenter Drug Assoc; 1966; 20(1):1-7. PubMed ID: 5900713
    [No Abstract]   [Full Text] [Related]  

  • 29. Parenteral formulations. II. A stability testing program for parenteral products.
    Lin SL
    Bull Parenter Drug Assoc; 1970; 24(2):83-93. PubMed ID: 5439917
    [No Abstract]   [Full Text] [Related]  

  • 30. Formulation of a parenteral antimalarial solution--a French undergraduate project in industrial pharmacy.
    Jeannin C; Pourcelot Y
    Am J Pharm Educ; 1977 Feb; 41(1):59-61. PubMed ID: 10236632
    [No Abstract]   [Full Text] [Related]  

  • 31. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Production in bigger plants].
    Schnorf U
    Pharm Acta Helv; 1973 Feb; 48(2):83-100. PubMed ID: 4706311
    [No Abstract]   [Full Text] [Related]  

  • 32. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Production in middle size plants].
    Bucher K
    Pharm Acta Helv; 1973 Feb; 48(2):101-16. PubMed ID: 4706308
    [No Abstract]   [Full Text] [Related]  

  • 33. IV fluidmakers: preparation of sterile water for injection in a field setting.
    Burrows WD; Nelson JH
    J Parenter Sci Technol; 1993; 47(3):124-9. PubMed ID: 8360804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use and sterility of multidose ophthalmic medications.
    Tamer HR; Sweet BV; Ross MB
    Am J Hosp Pharm; 1994 Feb; 51(4):500-2. PubMed ID: 8017416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recommended methods for compounding intravenous admixtures in hospitals.
    Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some theoretical aspects of bulk compounding technology. II. Suspensions.
    Am J Hosp Pharm; 1969 Sep; 26(9):548-50. PubMed ID: 5823458
    [No Abstract]   [Full Text] [Related]  

  • 37. Perspective on sterile compounding practices and the draft guidelines.
    Tormo VJ
    Am J Hosp Pharm; 1992 Apr; 49(4):946-7. PubMed ID: 1595725
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prescription moderated preparation of bacteria non-contaminated eyedrop solutions and eye ointment 1].
    Frauch P
    Pharm Acta Helv; 1970 Jan; 45(1):1-17. PubMed ID: 4908302
    [No Abstract]   [Full Text] [Related]  

  • 39. Joint commission to survey compliance with new USP-NF Chapter on compounding sterile preparations.
    Jt Comm Perspect; 2004 Apr; 24(4):4-5. PubMed ID: 15085694
    [No Abstract]   [Full Text] [Related]  

  • 40. Technology of eye drops containing aloe (Aloe arborescens Mill.--Liliaceae) and eye drops containing both aloe and neomycin sulphate.
    Kodym A; Marcinkowski A; KukuĊ‚a H
    Acta Pol Pharm; 2003; 60(1):31-9. PubMed ID: 12848365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.